RI
CMMB

RTW Investments’s Chemomab Therapeutics CMMB Stock Holding History

RTW Investments’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-811
Closed -$233K – 62
2019
Q2 		$233K Sell
811
-133
-14% -$46.3K 0.01% 52
2019
Q1 		$411K Buy
+944
New +$477K 0.03% 50

Other funds holding CMMB

MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

RTW Investments's CMMB Position: Q3 2019 in Review

RTW Investments sold out of Chemomab Therapeutics (CMMB) in Q3 2019, closing a stake of 811 shares — an estimated $233K sold.

RTW Investments first reported a position in CMMB in Q1 2019 and held it in 2 quarters. The position peaked at $411K in Q1 2019. 9 funds tracked by Wall St. Rank hold CMMB as of Q3 2019.

  • RTW Investments reported no remaining Chemomab Therapeutics position as of Q3 2019 after selling out during the quarter.
  • RTW Investments sold 811 Chemomab Therapeutics shares in Q3 2019, an estimated $233K.
  • RTW Investments first reported a position in Chemomab Therapeutics in Q1 2019 and held it in 2 quarters.
  • RTW Investments's Chemomab Therapeutics position peaked at $411K in Q1 2019.
  • 9 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q3 2019.

Based on RTW Investments's 13F filing for Q3 2019, filed 14 Nov 2019.